about
Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritisFunctional evolution of ADAMTS genes: evidence from analyses of phylogeny and gene organizationLymphoproliferative disorders in inflammatory bowel disease patients on immunosuppression: Lessons from other inflammatory disordersRisk of cancer among rheumatoid arthritis patients in California.TNFalpha kinoid vaccination-induced neutralizing antibodies to TNFalpha protect mice from autologous TNFalpha-driven chronic and acute inflammationTumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas.The British Society for Rheumatology biologics register.Lymphoma and other malignancies in primary Sjögren's syndrome: a cohort study on cancer incidence and lymphoma predictorsSafety analyses of adalimumab (HUMIRA) in global clinical trials and US postmarketing surveillance of patients with rheumatoid arthritis.Malignancy risk in Australian rheumatoid arthritis patients treated with anti-tumour necrosis factor therapy: analysis of the Australian Rheumatology Association Database (ARAD) prospective cohort studyThe safety of etanercept for the treatment of plaque psoriasis.Infliximab for the treatment of early rheumatoid arthritis.Design of effective immunotherapy for human autoimmunity.Optimizing Rheumatoid Arthritis Therapy: Using Objective Measures of Disease Activity to Guide Treatment.Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective studyBiologic agents in psoriasis.Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programmeInflammatory arthritis: an overview for primary care physicians.Carcinogenicity assessments of biotechnology-derived pharmaceuticals: a review of approved molecules and best practice recommendations.A decade of infliximab: The Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease.Multiple squamous cell carcinomas in the setting of psoriasis treated with etanercept: a report of four cases and review of the literature.Immunomodulation and lymphoma in humans.No overall increased risk of cancer in patients with rheumatoid arthritis: a nationwide dynamic cohort study in Taiwan.Methotrexate-associated primary hepatic malignant lymphoma following hepatectomy: A case report.Malignancy Incidence, Management, and Prevention in Patients with Rheumatoid Arthritis.Lymphoma in a patient with systemic lupus erythematosus.A case of multiple hepatic lesions associated with methotrexate-associated lymphoproliferative disorder.THE DIFFERENTIAL ALGORITHM BETWEEN RHEUMATOLOGIC AND MALIGN DISEASES.Risk of malignancy in patients with rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis under immunosuppressive therapy: a single-center experience.[Managing comorbidities of inflammatory rheumatic diseases].Sources of information on lymphoma associated with anti-tumour necrosis factor agents: comparison of published case reports and cases reported to the French pharmacovigilance system.[A case of recurrent breast cancer with life-threatening multiple lung metastasis markedly responding to CMF as third-line chemotherapy].Risk of Lymphoma in Inflammatory Bowel Disease.
P2860
Q24675306-AE680BEC-F1D5-4B3A-B265-20B9461318A3Q24805033-E706E68D-2891-489E-89DC-10664232621CQ26776151-93A4C8DA-18BE-460B-B101-F2B379CAC74EQ35162890-89F7FE04-88EE-4BC6-A22B-F683B9D842FEQ35540023-CC42B136-E99C-42A1-B55F-4C2936781A37Q35555527-621D33E9-8727-4A59-8801-886A3F912542Q35579512-CFC356A5-6354-49CA-819E-F2C778B4B165Q35637298-3482F0A9-8D30-4294-A174-CC998157A7D9Q35637322-90E31DE7-8996-4F2A-80FD-C50B25862B2BQ35813092-06C34ACA-12F1-4012-B0DF-56C439F1A489Q35919214-CF2CD637-3691-4FA7-A908-45CA2F765D4CQ36099482-24B5D790-D39C-4BF9-BD6D-8959EE9FB098Q36148416-77B5E9F9-9A88-45F7-8E26-4F1A4566B20BQ36257543-66F519DA-42F2-4FCC-B2E2-AC412672DBDAQ36281132-53821092-CD37-458B-A9EF-FAE82320ED74Q36620700-2B35FDF9-976C-491E-918C-ED68683221A7Q36859619-5B1987BB-AB55-4707-B0A0-A594B6F766B1Q37427257-CA966973-825D-4E68-A600-325EAAA37FA4Q37753534-C8A11BDD-7B1B-4377-9797-F604508096B4Q37814549-17A63D3D-0869-4576-BA1A-C952DED4D302Q37957993-07B64229-143E-4B7F-9309-E7F3353A93D8Q38112841-D023950B-0742-4330-A2EA-0A6737AAE88EQ38421453-F2854A08-7EE4-4B98-8055-623D3748D79EQ39026790-0F17E32C-A42B-40EA-94B3-6A0EEA1C2F3EQ39309064-389A682E-C090-4A41-9FD9-AE050BD8FC62Q40468437-3C43E1EA-57AC-451A-90F3-8730F860CD12Q40601244-BE6F0666-5A2A-488F-8BBB-ADC5D119C938Q40827731-E1619345-4802-4F90-86CE-23E2DC2501EDQ41650730-7DDA9E63-C834-4EB9-9F0B-B3189FB010ADQ44393048-E3502F34-FC26-47BD-B015-C70B2431455DQ46594660-88769242-CDCE-4BDA-B431-915F6725FD56Q46986955-8CEA3958-257A-458B-958F-68D66C55D226Q55533554-031274F4-1DCB-4CC2-B9C1-206BE3EFBE14
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Rheumatoid arthritis and malignant lymphomas.
@ast
Rheumatoid arthritis and malignant lymphomas.
@en
type
label
Rheumatoid arthritis and malignant lymphomas.
@ast
Rheumatoid arthritis and malignant lymphomas.
@en
prefLabel
Rheumatoid arthritis and malignant lymphomas.
@ast
Rheumatoid arthritis and malignant lymphomas.
@en
P2093
P1476
Rheumatoid arthritis and malignant lymphomas.
@en
P2093
Eva Baecklund
Johan Askling
Richard Rosenquist
P304
P356
10.1097/00002281-200405000-00014
P577
2004-05-01T00:00:00Z